The clinical management of relatives of young sudden unexplained death victims; implantable defibrillators are rarely indicated

Heart

Volumn 98, Issue 8, 2012, Pages 631-636

  Caldwell, Jane ^a,b   Moreton, Natalie ^c   Khan, Naz ^c   Kerzin Storrar, Lauren ^c   Metcalfe, Kay ^c   Newman, William ^c   Garratt, Clifford J ^a,b  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; PROPRANOLOL;

ADOLESCENT; ADULT; AGED; ARTICLE; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CAUSE OF DEATH; CHILD; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEFIBRILLATOR; DEVICE REMOVAL; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DRUG EFFECT; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EXERCISE ELECTROCARDIOGRAPHY; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; FAMILY ASSESSMENT; FAMILY HISTORY; FEMALE; FOLLOW UP; GENETIC SCREENING; HEART ARREST; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; QT PROLONGATION; RARE DISEASE; RELATIVE; RISK ASSESSMENT; SCHOOL CHILD; SUDDEN DEATH; TREATMENT DURATION; TREATMENT PLANNING;

ADULT; ALGORITHMS; CARDIOVASCULAR AGENTS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; GENETIC TESTING; HEART ARREST; HEART DEFECTS, CONGENITAL; HUMANS; MALE; MIDDLE AGED; PEDIGREE; PROGNOSIS; YOUNG ADULT;

EID: 84860133781     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-300924     Document Type: Article

References (30)

1. Behr E, Wood DA, Wright M, et al Sudden Arrhythmic Death Syndrome Steering Group. Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome. Lancet 2003;362:1457-9. (Pubitemid 37352884)
2. Department of Health, National Service Framework for Coronary Heart Disease - Chapter Eight:Arrhythmias and Sudden Cardiac Death, Gateway Reference: 4470, DH Coronary Heart Disease Team. 2005.
3. Nunn LM, Lambiase PD. Genetics and cardiovascular disease - causes and prevention of unexpected sudden adult death: the role of the SADS clinic. Heart 2011;97:1122-7.
4. Behr ER, Dalageorgou C, Christiansen M, et al. Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families. Eur Heart J 2008;29:1670-80. (Pubitemid 351957547)
5. Tan HL, Hofman N, van Langen IM, et al. Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation 2005;112:207-13. (Pubitemid 40982303)
6. van der Werf C, Hofman N, Tan HL, et al. Diagnostic yield in sudden unexplained death and aborted cardiac arrest in the young: the experience of a tertiary referral center in The Netherlands. Heart Rhythm 2010;7:1383-9.
7. Bai R, Napolitano C, Bloise R, et al. Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing. Circ Arrhythm Electrophysiol 2009;2:6-15.
8. Heart Rhythm UK Familial Sudden Death Syndromes Statement Development Group. Clinical indications for genetic testing in familial sudden cardiac death syndromes: an HRUK position statement. Heart 2008;94:502-7.
9. Hill SF, Sheppard MN. Non-atherosclerotic coronary artery disease associated with sudden cardiac death. Heart 2010;96:1119-25.
10. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J 2010;31:806-14.
11. Weiford BC, Subbarao VD, Mulhern KM. Noncompaction of the ventricular myocardium. Circulation 2004;109:2965-71. (Pubitemid 38808317)
12. Li L, Burke A, Zhang X, et al. Sudden unexpected death due to left ventricular noncompaction of myocardium: case report and review of the literature. Am J Forensic Med Pathol 2010;31:122-4.
13. Garratt CJ, Elliott P, Behr E, et al. Heart Rhythm UK position statement on clinical indications for implantable cardioverter defibrillators in adult patients with familial sudden cardiac death syndromes. Europace 2010;12:1156-75.
14. Vincent GM. Sudden cardiac arrest in the young due to inherited arrhythmias: the importance of family care. Pacing Clin Electrophysiol 2009;32(Suppl 2):S19-22.
15. Vincent GM, Schwartz PJ, Denjoy I, et al. High efficacy of beta-blockers in long QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of Beta-blocker treatment "failures". Circulation 2009;119:215-21.
16. Priori SG, Napolitano C, Schwartz PJ, et al. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. JAMA 2004;292:1341-4. (Pubitemid 39223225)
17. Schwartz PJ, Spazzolini C, Crotti L. All LQT3 patients need an ICD: true or false? Heart Rhythm 2009;6:113-20.
18. Antzelevitch C. Brugada syndrome. Pacing Clin Electrophysiol 2006;29:1130-59. (Pubitemid 44581402)
19. Hayashi M, Denjoy I, Extramiana F, et al. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia. Circulation 2009;119:2426-34.
20. Priori SG, Napolitano C, Memmi M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002;106:69-74. (Pubitemid 34747444)
21. Melacini P, Maron BJ, Bobbo F, et al. Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy. Heart 2007;93:708-10. (Pubitemid 46808272)
22. Maron BJ, Spirito P, Shen WK, et al. Implantable cardioverter- defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 2007;298:405-12. (Pubitemid 47124061)
23. Hamilton RM, Azevedo ER. Sudden cardiac death in dilated cardiomyopathies. Pacing Clin Electrophysiol 2009;32(Suppl 2):S32-40.
24. Wichter T, Borggrefe M, Haverkamp W, et al. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation 1992;86:29-37.
25. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006;48:e247-346. (Pubitemid 44382683)
26. Corrado D, Leoni L, Link MS, et al. Implantable cardioverter- defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2003;108:3084-91. (Pubitemid 38031796)
27. Wichter T, Paul M, Wollmann C, et al. Implantable cardioverter/ defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients. Circulation 2004;109:1503-8. (Pubitemid 38420178)
28. O'Mahony C, Lambiase PD, Quarta G, et al. The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy. Heart 2012;98:116-25.
29. Hendriks KS, Hendriks MM, Birnie E, et al. Familial disease with a risk of sudden death: a longitudinal study of the psychological consequences of predictive testing for long QT syndrome. Heart Rhythm 2008;5:719-24.
30. Ingles J, Lind JM, Phongsavan P, et al. Psychosocial impact of specialized cardiac genetic clinics for hypertrophic cardiomyopathy. Genet Med 2008;10:117-20. (Pubitemid 351271723)